Publication date: Mar 26, 2020 Our ability to combat the opioid epidemic depends, in part, on dismantling the stigma that surrounds drug use. However, this epidemic has been unique, and ... Read more

Publication date: Mar 23, 2020 To evaluate the association between opioid prescribing during pregnancy and new persistent opioid use in the year following delivery. This nationwide retrospective cohort study included ... Read more

Publication date: Mar 27, 2020 Recent guidelines advise limiting opioid prescriptions for acute pain to a three-day supply; however, scant literature quantifies opioid use patterns after an emergency department (ED) ... Read more

Publication date: Mar 27, 2020 Objective: This paper presents and discusses recent evidence on the pathophysiological mechanisms of pain. The role of tapentadol-an opioid characterized by an innovative mechanism of ... Read more

Publication date: Mar 24, 2020 Given the steep learning curve for neuraxial and peripheral nerve blocks, utilization of general anesthesia may increase as new house staff begin their residency programs. ... Read more

Publication date: Mar 25, 2020 Background: Optimal pain management in the palliative care setting often requires multiple pharmacological interventions including novel and off-label therapies. Ketamine is an anesthetic agent with ... Read more

Publication date: Mar 25, 2020 The opioid epidemic is currently a leading health crisis in the United States, and evidence supports Medication for Opioid Use Disorder (MOUD) as the most ... Read more

Publication date: Mar 25, 2020 In the wake of North America’s opioid crisis, access to evidence-based treatment for opioid use disorder (OUD) is of critical importance. While buprenorphine/naloxone and methadone ... Read more

Publication date: Mar 25, 2020 Opioid use disorder (OUD) poses medical and societal concerns. Although most individuals with OUD in the United States are not in drug abuse treatment, buprenorphine ... Read more

Publication date: Mar 25, 2020 The use of pharmacological treatments for opioid use disorders, including methadone, buprenorphine and naltrexone has been associated with a reduction in mortality compared with illicit ... Read more